During the weekend and through today, the Democratic Republic of the Congo noted 15 new Ebola cases, including in a report on another violent attack in Beni, the epicenter of the outbreak.
In other developments, plans plan to test experimental Ebola treatments in clinical trials, and Britain sends teams to assist with laboratory analysis and clinical trials.
New cases rise by 15
Of the 15 recently reported cases, 12 and 3 are confirmed as likely. A total of 334 cases today, including 296 confirmed and 38 probable cases. Eight more deaths were reported in the last 3 days and increased mortality to 206.
Of the latest diseases, based on the Ministry of Health's report November 10 and yesterday, 6 are from Beni, 2 are from the security group "Red Zone", the city of Kalunguta, 1 is from the Musien and 1 is from Kyondo, southeast of Butembo.
The remaining five cases, including three new likely diseases, are reflected in the overall World Health Organization (WHO) listed today in its electronic dashboard, and the sites are not specified. According to the latest information, health officials are still investigating 51 further suspected Ebola cases.
The number of vaccinated persons continues to rise steadily, and as of yesterday, the Ministry of Health said 28 727 were immunized, about half of them in Beni.
More violence in Beni
Yesterday, WHO General Director Tedros Adhanom Ghebreyesus told Twitter that he had been informed of a violent attack that occurred in Beni on the night of November 10th.
"All WHO are safe, but my heart goes out to families who have lost their dear in this scary and unacceptable attack, which we strongly condemn," he wrote.
According to a local media report translated and published by H5N1 Blog, focusing on infectious disease news, at least five civilians were killed and several children were kidnapped in an attack by rebels with the Allied Democratic Forces (ADF) in Beni's Mayimoya district.
The report said two other people were killed in two other attacks on the same day in Beni Runwenzori district, one linked to ADF rebels and the other by suspected members in Mai Mai.
Beni has experienced several violent attacks, one in September that led to a general mourning period and temporarily ceased the eruption of reaction measures.
The free round of attacks comes on the heels of a high-level visit by the WHO and UN peacekeeping officials to address security issues related to armed rebel groups and pockets of distrust from society driven by the failure of the DRC government to control land and protect citizens in the eastern part of the country where outbreaks occur.
The study for therapies takes shape
In a report from State today, health officials said that plans were gathered to launch a clinical trial in the field of excretion to test three antibody treatments and one antiviral drug against each other, a complicated effort that is committed to spreading several future outbreaks in affected countries.
The experimental drugs are already used in Ebola treatment centers due to compassionate use. They include three monoclonal antibodies (ZMapp, REGN 3470-3471-3479, and mAB 114) and the antiviral drug Remdesivir.
According to the state, 139 patients have been treated with one of the four drugs.
Jamie Farrar, PhD student, PhD student of Wellcome Trust, told Stat that the randomized controlled study is likely to start sometime in November and that the DRC National Institute of Biomedical Research will be a trial sponsor. A final plan awaits review of the study protocol by the DRC government's ethics adviser.
Britain's team leads to a breakaway area
Experts from the United Kingdom are ready to travel to the Democratic Republic of the Congo, reported Sky News today, citing Daniel Bausch, MD, MPH, who heads a quick response jointly run by Public Health England and the London School of Hygiene and Tropical Medicine.
He said the group will contain two teams, one of them a six-person lab team that will help with genetic sequencing to better identify transfer patterns, and the other a two-person team to initially work with clinical trials.
According to the report, the law is expected to arrive at the end of the week, arriving at Kinshasa and collaborating with colleagues from the WHO and the United States National Institute for Health. They will then travel to Beni if the conditions are safe. Bausch said that a senior epidemiologist had been in the outbreak region early in the epidemic for rapid risk assessment and is slated to return.
November 10 DRC Update
November 11 DRC Update
WHO Ebola dashboard
Tedros Twitter account
November 11 H5N1 Blog post
Nov 12 Stat History
Nov 12 Sky News story